NYKODE THERAPEUTICS ASA earnings per share and revenue

5VB earnings per share for the last quarter are -0.02 EUR whereas the estimation was -0.05 EUR which accounts for 53.91% surprise. Company revenue for the same period amounts to 525.63 k EUR despite the estimated figure of 3.69 M EUR. Estimated earnings per share for the next quarter are -0.04 EUR, and revenue is expected to reach 2.68 M EUR. Also watch annual changes over time to get a bigger picture of 5VB earnings per share and revenue dynamics.